Skip to content
DefDex

Federal award

NOVADIGM THERAPEUTICS, INC.

W81XWH16C0125

Contract

Obligated and Ceiling

Obligated (net)
$3,735,479.26
Ceiling (potential value, not spending)
$3,735,479.26
Current value
$3,735,479.26
Gross positive obligations
$3,758,964.11

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
NOVADIGM THERAPEUTICS, INC. · CBW9AN2E4WA6
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
NOVADIGM THERAPEUTICS, INC. · CBW9AN2E4WA6
Awarding agency
Department of War · sub-agency 2100 · office W81XWH
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN92 · R&D- MEDICAL: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS)
541690 · OTHER SCIENTIFIC AND TECHNICAL CONSULTING SERVICES
PIID
W81XWH16C0125
Award type code
D
Actions
5 · Sep 15, 2016 to May 14, 2020
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History5

Award actions
DateFYModAction typeObligationCompany in company totals
May 14, 2020FY2020P00004M−$23,484.85
—
Nov 1, 2018FY2019P00003B$589,200.00
—
Jul 19, 2017FY2017P00002B$0.00
—
Oct 6, 2016FY2017P00001M$0.00
—
Sep 15, 2016FY20160—$3,169,764.11
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.